| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A novel validated tool to score symptom burden in exercise-induced laryngeal obstruction: can we simplify patient follow-up and research?
|
Halvorsen, Thomas
|
|
|
10 |
2 |
p. 131-132
|
artikel
|
| 2 |
Awake prone positioning for COVID-19 acute respiratory failure: imaging and histological background
|
Piciucchi, Sara
|
|
|
10 |
2 |
p. e14
|
artikel
|
| 3 |
Bedside ultrasonography to determine pleurodesis success: SIMPLE but how sound?
|
Lee, Y C Gary
|
|
|
10 |
2 |
p. 122-123
|
artikel
|
| 4 |
Cystic fibrosis: a call for papers for ECFS 2022
|
Grainger, Emma
|
|
|
10 |
2 |
p. 130
|
artikel
|
| 5 |
Fourth dose of COVID-19 vaccines in Israel
|
Burki, Talha Khan
|
|
|
10 |
2 |
p. e19
|
artikel
|
| 6 |
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study
|
Gangneux, Jean-Pierre
|
|
|
10 |
2 |
p. 180-190
|
artikel
|
| 7 |
GOLD report: 2022 update
|
Venkatesan, Priya
|
|
|
10 |
2 |
p. e20
|
artikel
|
| 8 |
Improving lifelong respiratory health after preterm birth
|
The Lancet Respiratory Medicine,
|
|
|
10 |
2 |
p. 121
|
artikel
|
| 9 |
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trial
|
Mazeraud, Aurélien
|
|
|
10 |
2 |
p. 158-166
|
artikel
|
| 10 |
Intravenous immunoglobulin therapy for COVID-19 ARDS
|
Wilfong, Erin M
|
|
|
10 |
2 |
p. 123-125
|
artikel
|
| 11 |
Jab
|
Boggon, Adam
|
|
|
10 |
2 |
p. 136-138
|
artikel
|
| 12 |
Living with severe asthma as a teenager
|
Kirby, Tony
|
|
|
10 |
2 |
p. 134-136
|
artikel
|
| 13 |
Managing secondary fungal infections in severe COVID-19: how to move forward?
|
Verweij, Paul E
|
|
|
10 |
2 |
p. 127-128
|
artikel
|
| 14 |
Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research
|
Weerakkody, Sampath
|
|
|
10 |
2 |
p. 199-213
|
artikel
|
| 15 |
Omicron variant and booster COVID-19 vaccines
|
Burki, Talha Khan
|
|
|
10 |
2 |
p. e17
|
artikel
|
| 16 |
Postoperative CPAP after major abdominal surgery
|
Tandabany, Sharmila
|
|
|
10 |
2 |
p. e11
|
artikel
|
| 17 |
Postoperative CPAP after major abdominal surgery – Authors' reply
|
Abbott, Tom
|
|
|
10 |
2 |
p. e12-e13
|
artikel
|
| 18 |
Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis
|
Higbee, Daniel H
|
|
|
10 |
2 |
p. 149-157
|
artikel
|
| 19 |
Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia
|
Vincent, Jean-Louis
|
|
|
10 |
2 |
p. 214-220
|
artikel
|
| 20 |
Respiratory diseases advocate living with severe asthma
|
Kirby, Tony
|
|
|
10 |
2 |
p. 132-134
|
artikel
|
| 21 |
Risk of COVID-19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study
|
Shi, Ting
|
|
|
10 |
2 |
p. 191-198
|
artikel
|
| 22 |
Risk of COVID-19 hospital admission among children with asthma
|
Harwood, Rachel
|
|
|
10 |
2 |
p. 128-130
|
artikel
|
| 23 |
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial
|
Psallidas, Ioannis
|
|
|
10 |
2 |
p. 139-148
|
artikel
|
| 24 |
Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial
|
Toback, Seth
|
|
|
10 |
2 |
p. 167-179
|
artikel
|
| 25 |
Thank you to The Lancet Respiratory Medicine's clinical and statistical peer reviewers in 2021
|
The Lancet Respiratory Medicine Editors,
|
|
|
10 |
2 |
p. e21-e24
|
artikel
|
| 26 |
The role of antiviral treatment in the COVID-19 pandemic
|
Burki, Talha Khan
|
|
|
10 |
2 |
p. e18
|
artikel
|
| 27 |
Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines
|
Altmann, Daniel M
|
|
|
10 |
2 |
p. 125-126
|
artikel
|
| 28 |
Why the application of IVIG might be beneficial in patients with COVID-19
|
Kindgen-Milles, Detlef
|
|
|
10 |
2 |
p. e15
|
artikel
|
| 29 |
Why the application of IVIG might be beneficial in patients with COVID-19 – Authors' reply
|
Mazeraud, Aurélien
|
|
|
10 |
2 |
p. e16
|
artikel
|
Tijdschrift beschrijving